These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 897662)

  • 41. Inhibition of uterine estrogen receptor transformation by sodium molybdate.
    Shyamala G; Leonard L
    J Biol Chem; 1980 Jul; 255(13):6028-31. PubMed ID: 7391003
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Anti-estrogen interaction with uterine estrogen receptors. Studies with a radiolabeled anti-estrogen (CI-628).
    Katzenellenbogen BS; Katzenellenbogen JA; Ferguson ER; Krauthammer N
    J Biol Chem; 1978 Feb; 253(3):697-707. PubMed ID: 621199
    [No Abstract]   [Full Text] [Related]  

  • 43. The binding of tamoxifen to oestrogen receptor proteins under equilibrium and non-equilibrium conditions.
    Nicholson RI; Syne JS; Daniel CP; Griffiths K
    Eur J Cancer (1965); 1979 Mar; 15(3):317-29. PubMed ID: 446514
    [No Abstract]   [Full Text] [Related]  

  • 44. Estrogen receptors in cultured rat uterine cells: induction of progesterone receptors in the absence of estrogen receptor processing.
    Kassis JA; Walent JH; Gorski J
    Endocrinology; 1986 Feb; 118(2):603-8. PubMed ID: 3943487
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Facilitation and inhibition of the estrogen-induced luteinizing hormone surge in the rat by progesterone: effects on cytoplasmic and nuclear estrogen receptors in the hypothalamus-preoptic area, pituitary, and uterus.
    Attardi B
    Endocrinology; 1981 Apr; 108(4):1487-96. PubMed ID: 7472278
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Estrogen action in the mouse uterus: characterization of the cytosol and nuclear receptor systems.
    Korach KS
    Endocrinology; 1979 May; 104(5):1324-32. PubMed ID: 436778
    [No Abstract]   [Full Text] [Related]  

  • 47. Characterization of an antiidiotypic antibody mimicking the actions of estradiol and its interaction with estrogen receptors.
    Mor G; Amir-Zaltsman Y; Barnard G; Kohen F
    Endocrinology; 1992 Jun; 130(6):3633-40. PubMed ID: 1597160
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Characterization of estrogen binding in uterine cytosol from the fetal rhesus monkey.
    Kimmel GL; Harmon JR; Slikker W
    Teratog Carcinog Mutagen; 1983; 3(4):355-65. PubMed ID: 6138868
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The alpha 1-noradrenergic antagonist prazosin decreases the concentration of estrogen receptors in female rat hypothalamus.
    Blaustein JD
    Brain Res; 1987 Feb; 404(1-2):39-50. PubMed ID: 2882810
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Molecular and functional anomalies in the mechanism of the estrogenic action of 4-mercuri-17 beta-estradiol.
    Muldoon TG
    J Biol Chem; 1980 Feb; 255(4):1358-66. PubMed ID: 7354031
    [No Abstract]   [Full Text] [Related]  

  • 51. The binding of rat uterine cytosol oestrogen receptor to oligothymidylate-cellulose: further evidence for the presence of a cytosol activating factor [proceedings].
    Myatt L; Elder MG; Lim L
    Biochem Soc Trans; 1979 Oct; 7(5):909-10. PubMed ID: 510738
    [No Abstract]   [Full Text] [Related]  

  • 52. Determination of cytosol and nuclear estradiol-binding sites in fetal guinea pig uterus by [3H]estradiol exchange.
    Sumida C; Pasqualini JR
    Endocrinology; 1979 Aug; 105(2):406-13. PubMed ID: 456319
    [No Abstract]   [Full Text] [Related]  

  • 53. Estrogen receptor binding affinity and uterotrophic activity of triphenylhaloethylenes.
    DeSombre ER; Mease RC; Sanghavi J; Singh T; Seevers RH; Hughes A
    J Steroid Biochem; 1988 Jun; 29(6):583-90. PubMed ID: 3386226
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Steroid receptor forms and their interaction with cytoplasmic modulators.
    Sato B; Nishizawa Y; Maeda Y; Noma K; Honma T; Matsumoto K
    J Steroid Biochem; 1983 Jul; 19(1A):315-21. PubMed ID: 6887866
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Differentiation of estradiol receptors in rat uterine cytosol by sensitivity to tamoxifen.
    Fishman JH; Fishman J
    Biochem Biophys Res Commun; 1979 Mar; 87(2):550-8. PubMed ID: 444239
    [No Abstract]   [Full Text] [Related]  

  • 56. A modulator which converts activated estrogen receptor to a biologically inactive aggregated form.
    Nishizawa Y; Maeda Y; Noma K; Sato B; Matsumoto K; Yamamura Y
    Endocrinology; 1981 Nov; 109(5):1463-72. PubMed ID: 6795027
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The thermolability of rat uterine cytosol estrogen receptors: basis for a novel cytosol exchange-denaturation assay.
    Woosley JT; Muldoon TG
    J Steroid Biochem; 1979 Aug; 11(2):1065-71. PubMed ID: 502549
    [No Abstract]   [Full Text] [Related]  

  • 58. Ribosome-associated estradiol-binding components in the uterus and their relationship to the translational capacity of uterine ribosomes.
    Labate ME; Whelly SM; Barker KL
    Endocrinology; 1986 Jul; 119(1):140-51. PubMed ID: 3720662
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Chloro-s-triazine antagonism of estrogen action: limited interaction with estrogen receptor binding.
    Tennant MK; Hill DS; Eldridge JC; Wetzel LT; Breckenridge CB; Stevens JT
    J Toxicol Environ Health; 1994 Oct; 43(2):197-211. PubMed ID: 7932849
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Identification of immunoassayable estrogen receptor lacking hormone binding ability in tamoxifen-treated rat uterus.
    Nakao M; Sato B; Koga M; Noma K; Kishimoto S; Matsumoto K
    Biochem Biophys Res Commun; 1985 Oct; 132(1):336-42. PubMed ID: 3904747
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.